Filing Details
- Accession Number:
- 0001209191-20-064184
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-17 18:08:22
- Reporting Period:
- 2020-12-15
- Accepted Time:
- 2020-12-17 18:08:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 906709 | Nektar Therapeutics | NKTR | Pharmaceutical Preparations (2834) | 943134940 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1632901 | Curet Myriam | C/O Nektar Therapeutics 455 Mission Bay Blvd South, Suite 100 San Francisco CA 94158 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-12-15 | 1,560 | $17.82 | 19,240 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Represents the number of shares sold by the reporting person to cover tax obligations in connection with the vesting of restricted stock units.
Billionaire Hedge Funds
